Ginkgo Bioworks Holdings, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ginkgo Bioworks Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q2 2024.
  • Ginkgo Bioworks Holdings, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$223M, a 21.1% decline year-over-year.
  • Ginkgo Bioworks Holdings, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$865M, a 32.7% increase year-over-year.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2023 was -$864M, a 60.9% increase from 2022.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2022 was -$2.21B, a 20.8% decline from 2021.
  • Ginkgo Bioworks Holdings, Inc. annual Operating Income (Loss) for 2021 was -$1.83B, a 1234% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$865M -$223M -$38.8M -21.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$827M -$178M +$37.7M +17.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$864M -$178M +$52.7M +22.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$917M -$286M +$369M +56.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$1.29B -$184M +$464M +71.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$1.75B -$216M +$460M +68.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$2.21B -$231M +$1.45B +86.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$3.66B -$655M -$628M -2356% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$3.03B -$648M -$588M -981% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$2.45B -$675M -$618M -1082% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$1.83B -$1.68B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 -$26.7M +$7.74M +22.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$59.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$57.1M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$34.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.